Skip to main content

Nicotine Mini

NDC 59726-652 · P & L Development, LLC

Generic nameNicotine Polacrilex
Dosage formLOZENGE
RouteORAL
Active ingredient(s)NICOTINE
Strength4 mg/1
Pharmacologic classCholinergic Nicotinic Agonist [EPC], Nicotine [CS]
Marketing categoryANDA

Packages

59726-652-04 — 5 BOTTLE, PLASTIC in 1 BOX (59726-652-04) / 27 LOZENGE in 1 BOTTLE, PLASTIC

59726-652-27 — 1 BOTTLE, PLASTIC in 1 BOX (59726-652-27) / 27 LOZENGE in 1 BOTTLE, PLASTIC

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

58602-906 — NICOTINE POLACRILEX, 59450-001 — Nicotine, 59450-002 — Nicotine, 59450-003 — Nicotine, 59640-099 — Nicotine Polacrilex, 59640-151 — nicotine polacrilex, 59726-262 — nicotine polacrilex, 59726-264 — nicotine polacrilex, 59726-592 — Nicotine Polacrilex, 59726-650 — nicotine polacrilex, 59726-913 — Nicotine Polacrilex, 59726-929 — nicotine polacrilex, 59726-935 — nicotine polacrilex, 59779-201 — Nicotine Polacrilex, 59779-344 — Nicotine Polacrilex, 59779-397 — Nicotine Polacrilex, 59779-424 — Nicotine polacrilex, 59779-443 — Nicotine, 59779-445 — Nicotine, 59779-448 — Nicotine, +734 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels